暂无分享,去创建一个
J. T. Thigpen
[1] Chris Twelves,et al. Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study , 2011, The Lancet.